DE60232197D1 - Verfahren zur aufreinigung von glykopeptid phosphonatderivaten - Google Patents

Verfahren zur aufreinigung von glykopeptid phosphonatderivaten

Info

Publication number
DE60232197D1
DE60232197D1 DE60232197T DE60232197T DE60232197D1 DE 60232197 D1 DE60232197 D1 DE 60232197D1 DE 60232197 T DE60232197 T DE 60232197T DE 60232197 T DE60232197 T DE 60232197T DE 60232197 D1 DE60232197 D1 DE 60232197D1
Authority
DE
Germany
Prior art keywords
purifying
phosphonate derivatives
glycopeptide phosphonate
purifying glycopeptide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60232197T
Other languages
English (en)
Inventor
Donald Schmidt Jr
Jeanmarie Donovan Sganga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innoviva Inc
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Application granted granted Critical
Publication of DE60232197D1 publication Critical patent/DE60232197D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60232197T 2001-08-24 2002-08-23 Verfahren zur aufreinigung von glykopeptid phosphonatderivaten Expired - Lifetime DE60232197D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31471201P 2001-08-24 2001-08-24
PCT/US2002/026854 WO2003018608A2 (en) 2001-08-24 2002-08-23 Process for purifying glycopeptide phosphonate derivatives

Publications (1)

Publication Number Publication Date
DE60232197D1 true DE60232197D1 (de) 2009-06-10

Family

ID=23221118

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60232197T Expired - Lifetime DE60232197D1 (de) 2001-08-24 2002-08-23 Verfahren zur aufreinigung von glykopeptid phosphonatderivaten

Country Status (14)

Country Link
US (5) US7015307B2 (de)
EP (1) EP1487863B1 (de)
JP (1) JP4116547B2 (de)
KR (1) KR100905009B1 (de)
CN (1) CN100418980C (de)
AT (1) ATE430159T1 (de)
AU (1) AU2002326740A1 (de)
CA (1) CA2457218C (de)
DE (1) DE60232197D1 (de)
DK (1) DK1487863T3 (de)
ES (1) ES2324771T3 (de)
NO (1) NO330734B1 (de)
TW (1) TWI233932B (de)
WO (1) WO2003018608A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
TWI233932B (en) * 2001-08-24 2005-06-11 Theravance Inc Process for purifying glycopeptide phosphonate derivatives
TWI342312B (en) 2003-10-22 2011-05-21 Theravance Inc Hydrochloride salts of a glycopeptide phosphonate derivative
EP1818340A4 (de) 2004-11-29 2009-02-25 Univ Nagoya Nat Univ Corp Antibiotische monomere glykopeptidderivate
TW200808818A (en) * 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
US20090069219A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched telavancin
AU2008343502A1 (en) * 2007-12-26 2009-07-09 Biomarin Pharmaceutical Inc. Novel semi-synthetic glycopeptides as antibacterial agents
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
CN103105327A (zh) * 2011-11-11 2013-05-15 中国科学院大连化学物理研究所 采用金属氧化物富集糖肽的通用方法
US9753436B2 (en) 2013-06-11 2017-09-05 Apple Inc. Rotary input mechanism for an electronic device
CN109766020B (zh) 2013-08-09 2022-04-29 苹果公司 用于电子设备的触觉开关
CN107759672A (zh) 2013-08-19 2018-03-06 南京爱斯药业有限公司 万古霉素衍生物、制备方法及其应用
WO2015122885A1 (en) 2014-02-12 2015-08-20 Bodhi Technology Ventures Llc Rejection of false turns of rotary inputs for electronic devices
US10190891B1 (en) 2014-07-16 2019-01-29 Apple Inc. Optical encoder for detecting rotational and axial movement
CN205121417U (zh) 2014-09-02 2016-03-30 苹果公司 可穿戴电子设备
TN2017000358A1 (en) 2015-02-23 2019-01-16 Theravance Biopharma Antibiotics Ip Llc Doses and methods of administering telavancin
CN105985412A (zh) * 2015-02-28 2016-10-05 爱斯医药科技(南京)有限公司 万古霉素衍生物、制备方法及其应用
JP6515185B2 (ja) 2015-03-05 2019-05-15 アップル インコーポレイテッドＡｐｐｌｅ Ｉｎｃ． 方向依存光学特性を有する光学エンコーダを有する時計、手首装着型電子デバイス及びウェラブル電子デバイス
KR102163612B1 (ko) 2015-03-08 2020-10-08 애플 인크. 회전 및 병진 가능한 입력 메커니즘을 갖는 시계
US10018966B2 (en) 2015-04-24 2018-07-10 Apple Inc. Cover member for an input mechanism of an electronic device
US9891651B2 (en) 2016-02-27 2018-02-13 Apple Inc. Rotatable input mechanism having adjustable output
CN107325159A (zh) * 2016-04-29 2017-11-07 中国科学院上海药物研究所 一类万古霉素衍生物、其制备方法、药物组合物和用途
US10551798B1 (en) 2016-05-17 2020-02-04 Apple Inc. Rotatable crown for an electronic device
US10061399B2 (en) 2016-07-15 2018-08-28 Apple Inc. Capacitive gap sensor ring for an input device
US10019097B2 (en) 2016-07-25 2018-07-10 Apple Inc. Force-detecting input structure
US10664074B2 (en) 2017-06-19 2020-05-26 Apple Inc. Contact-sensitive crown for an electronic watch
US10962935B1 (en) 2017-07-18 2021-03-30 Apple Inc. Tri-axis force sensor
US11360440B2 (en) 2018-06-25 2022-06-14 Apple Inc. Crown for an electronic watch
US11561515B2 (en) 2018-08-02 2023-01-24 Apple Inc. Crown for an electronic watch
CN211293787U (zh) 2018-08-24 2020-08-18 苹果公司 电子表
US11181863B2 (en) 2018-08-24 2021-11-23 Apple Inc. Conductive cap for watch crown
CN209625187U (zh) 2018-08-30 2019-11-12 苹果公司 电子手表和电子设备
US11194298B2 (en) 2018-08-30 2021-12-07 Apple Inc. Crown assembly for an electronic watch
US11194299B1 (en) 2019-02-12 2021-12-07 Apple Inc. Variable frictional feedback device for a digital crown of an electronic watch
US11550268B2 (en) 2020-06-02 2023-01-10 Apple Inc. Switch module for electronic crown assembly
US11983035B2 (en) 2020-06-11 2024-05-14 Apple Inc. Electronic device

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440753A (en) 1982-03-15 1984-04-03 Eli Lilly And Company Purification of glycopeptide antibiotics using non-functional resins
US4667024A (en) 1983-07-13 1987-05-19 Smithkline Beckman Corporation Process for the preparation of purified vancomycin class antibiotics
GB8608798D0 (en) 1986-04-11 1986-05-14 Lepetit Spa Recovery of glycopeptide antibiotics from aqueous solutions
US4845104A (en) * 1986-11-20 1989-07-04 Merck & Co., Inc. Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones
US4845194A (en) * 1987-02-27 1989-07-04 Eli Lilly And Company Glycopeptide recovery process
US4874843A (en) 1987-12-03 1989-10-17 Eli Lilly And Company Chromatographic purification process
US4996148A (en) * 1987-07-13 1991-02-26 Eli Lilly And Company A80407 antibiotics
JP2577133B2 (ja) 1989-11-27 1997-01-29 スティフティング フォール ド テフニスヘ ウェッテンスハッペン 船舶のプロペラ
US5149784A (en) 1990-07-10 1992-09-22 Abbott Laboratories Process for making vancomycin
US5258495A (en) 1990-07-10 1993-11-02 Abbott Laboratories Process for making vancomycin HC1
DE4039451A1 (de) * 1990-12-11 1992-06-17 Hoechst Ag Metallocene mit bicyclischen cyclopentadienderivaten als liganden, verfahren zu ihrer herstellung und ihre verwendung als katalysatoren
EP0640095B1 (de) 1992-04-20 1998-07-01 Abbott Laboratories Verfahren zur herstellung von vancomycin
UA43323C2 (uk) * 1994-01-28 2001-12-17 Елі Ліллі Енд Компані Антибіотичні похідні глікопептидів, спосіб отримання та фармацевтична композиція
SI9500039B (sl) 1995-02-07 2002-02-28 Lek, Nov kombiniran postopek čiščenja Vankomicin hidroklorida
WO1998026085A1 (fr) 1996-12-11 1998-06-18 Nippon Kayaku Kabushiki Kaisha Procedes de fabrication de vancomycine
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
TWI233932B (en) * 2001-08-24 2005-06-11 Theravance Inc Process for purifying glycopeptide phosphonate derivatives

Also Published As

Publication number Publication date
US7468420B2 (en) 2008-12-23
EP1487863B1 (de) 2009-04-29
US20060100415A1 (en) 2006-05-11
CN1671732A (zh) 2005-09-21
KR20040028998A (ko) 2004-04-03
CA2457218A1 (en) 2003-03-06
US20080103290A1 (en) 2008-05-01
JP2005505542A (ja) 2005-02-24
US7858583B2 (en) 2010-12-28
ES2324771T3 (es) 2009-08-14
NO20040768L (no) 2004-04-29
US20030119722A1 (en) 2003-06-26
US20090215673A1 (en) 2009-08-27
US7015307B2 (en) 2006-03-21
CN100418980C (zh) 2008-09-17
DK1487863T3 (da) 2009-07-13
US20110257364A1 (en) 2011-10-20
US7375181B2 (en) 2008-05-20
EP1487863A2 (de) 2004-12-22
CA2457218C (en) 2011-08-02
EP1487863A4 (de) 2007-08-29
JP4116547B2 (ja) 2008-07-09
TWI233932B (en) 2005-06-11
NO330734B1 (no) 2011-06-27
WO2003018608A2 (en) 2003-03-06
WO2003018608A8 (en) 2003-04-24
KR100905009B1 (ko) 2009-06-29
WO2003018608A3 (en) 2004-10-07
ATE430159T1 (de) 2009-05-15
AU2002326740A1 (en) 2003-03-10

Similar Documents

Publication Publication Date Title
DE60232197D1 (de) Verfahren zur aufreinigung von glykopeptid phosphonatderivaten
IS6600A (is) Glýkópeptíð fosfónatafleiður
ATE322681T1 (de) Inhibitoren für wachstumdifferenzierungsfaktor und ihre anwendungen
ATE529409T1 (de) Verfahren zur herstellung von kristallinen aripiprazolformen
DE59900390D1 (de) Verfahren zur Herstellung von Olefinen
DE69920945D1 (de) Verfahren zur herstellung von arzneistoffpartikeln
ATE468317T1 (de) Herstellung von 1,3-diphenylprop-2-en-1- onderivaten
DE602004017731D1 (de) Verfahren zur herstellung von 1-ä(benzimidazol-1-yl)chinolin-8-ylüpiperidin-4-ylaminderivaten
DE60330146D1 (de) Verfahren zur reinigung von fibrinogen
DE59605527D1 (de) Verfahren zur Reinigung von wasserlöslichen Cyclodextrinderivaten
ATE428942T1 (de) Verfahren und zusammensetzungen zur herstellung von ophtalmischen linsen
DE60204334D1 (de) Verfahren zur herstellung von repaglinide
DE60124289D1 (de) Verfahren zur herstellung von 21-hydroxy-6,19-oxidoprogesteron (21oh-6op)
DE50014421D1 (de) Verfahren zur Hydrierung von Aceton
DE60215867D1 (de) Verfahren zur herstellung von penamderivaten aus cephamderivaten
DE69934948D1 (de) Verfahren zur cooxidation von organischen verbindungen
IS6914A (is) 2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum
DE69430079T2 (de) Verfahren zur Herstellung von Oenothein-B aus Epilobium Parviflorum
DE69500327T2 (de) Verfahren zur Herstellung von azithromycin Dihydrochloriden
ATE275149T1 (de) Verfahren zur herstellung von taxanderivaten
DE60222806D1 (de) Verfahren zur herstellung von (1,4,5)-oxadiazepinderivaten
DE59603661D1 (de) Verfahren zur Herstellung von Polyisoolefinen mittels neuer Initiatorsysteme
DE50010478D1 (de) Verfahren zur herstellung von polyamiden
BRPI0408077A (pt) composições e métodos para prevenção e tratamento de doenças relacionadas com endotoxina e condições
DE50203388D1 (de) Verbessertes verfahren zur herstellung von bisphosphiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition